The acronym UFE stands for Uterine Fibroid Embolization, a minimally invasive medical procedure used to treat uterine fibroids. Uterine fibroids are noncancerous growths that develop in and around the uterus, affecting many women during their reproductive years. UFE involves blocking the blood flow to the fibroids, causing them to shrink and ultimately die.
During the UFE procedure, the patient is usually sedated but remains conscious. Under the guidance of medical imaging techniques, such as fluoroscopy or ultrasound, an interventional radiologist inserts a catheter through a small incision in the groin area and navigates it to the site of the fibroids. Small particles or beads are then injected through the catheter, directed towards the arteries supplying blood to the fibroids. These particles block the blood vessels and restrict the flow of blood, leading to the fibroids' deprivation of oxygenated blood and nutrients. Over time, the fibroids shrink, relieve symptoms, and reduce the need for invasive surgical interventions like hysterectomy.
UFE typically offers a shorter recovery time, less scarring, and a lower risk of complications compared to traditional surgical options. Common side effects may include pain, nausea, and fatigue immediately following the procedure, but they usually subside within a few days. UFE may result in temporary or permanent cessation of menstrual periods, and rarely, complications like infection or damage to the uterus or nearby organs may occur.
Overall, UFE has become a popular alternative to surgery for managing symptomatic uterine fibroids, providing relief for many patients while preserving their fertility.
